Latest news
US Claims Study Finds Modest Uptake of Injectable Cabotegravir PrEP - Consultant360Consultant360 · Thu, 06 Aug 2026 12:33:32 GMTNo HIV Infections Seen With Cabotegravir PrEP in Real-World Study - Contagion LiveContagion Live · Tue, 04 Aug 2026 23:08:11 GMTCabotegravir, Rilpivirine Outperforms Daily HIV Therapy in Adolescents - Drug TopicsDrug Topics · Tue, 04 Aug 2026 16:07:51 GMTCabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions - MedPage TodayMedPage Today · Mon, 03 Aug 2026 21:12:11 GMTNew HIV Frontier: The Fight To Access Long-Acting Prevention Drugs - Health Policy WatchHealth Policy Watch · Wed, 29 Jul 2026 07:00:00 GMTCabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT